34 How MCP-1 modulates oxidative stress pathways or reduces antio

34 How MCP-1 modulates oxidative stress pathways or reduces antioxidants Smoothened inhibitor will be investigated in the future. Similar up-regulation of microsomal CYP2E135 in alcohol-fed WT and MCP-1KO mice indicate the induction of oxidative stress independent of alcohol-metabolizing CYP2E1. Besides cellular mechanisms, such as TLR expression, oxidative stress contributes to LPS sensitization in ALD and enhancement of pro inflammatory cytokine gene expression.36, 37 An in vivo LPS challenge given at the end of chronic alcohol feeding led to an augmentation of proinflammatory cytokines TNFα, IL-1β, and IL-6 in WT mice, and this was prevented in MCP-1KO mice. Our results suggest that MCP-1 deficiency

inhibits oxidative stress and also impedes sensitization to LPS, independent of TLR4 expression, during alcoholic

liver injury. Studies to unravel the mechanisms of LPS sensitization affected click here by MCP-1 during chronic alcohol exposure will be examined in the future. Among the various mechanistic studies for alcoholic steatosis, alterations in transcription factors, such as PPARα and PPARγ, controlling lipid metabolism have been recognized.24 Previous studies showed that alcohol feeding in rats decreased PPARα activation and downstream target genes important in fatty acid oxidation.19 Here, we show that alcohol-fed MCP-1KO mice exhibit increased PPARα and PPARγ mRNA expression, enhanced nuclear PPARα and PPARγ, PPRE activation in whole liver and isolated hepatocytes, presence

of PPARα/RXRα in the DNA-binding complex, and induction of target genes, such as CPT-1 and ACOX—both enzymes critical in fatty acid oxidation. Previous studies have shown that a secretory product of adipose tissue, likely MCP-1, can induce lipid accumulation in hepatoyctes.13 Our in vitro findings demonstrate that recombinant MCP-1 down-regulates PPARα mRNA expression and DNA-binding activity in hepatocytes, likely contributing to increased triglyceride accumulation in ALD. These results suggest a direct effect of MCP-1 on PPARα and medchemexpress its target genes and thus steatosis. MCP-1 mediates its action via receptor CCR238 or independent of CCR2.39 Our results show that CCR2KO mice induce alcoholic liver injury similar to alcohol-fed WT mice, indicating CCR2-independent effects of MCP-1. Furthermore, because hepatocytes do not express CCR2,18 as reported here (Supporting Fig. 5A), we predict that MCP-1 mediates its effects in the liver independent of CCR2. Another lipid-modulating transcription factor with anti-inflammatory properties, PPARγ, was up-regulated in alcohol-fed MCP-1KO livers. It is likely that PPARγ inhibits proinflammatory cytokine production in chronic alcohol-exposed MCP-1KO mice. Our results here show that MCP-1 expression is directly up-regulated in hepatocytes during chronic alcohol exposure and likely regulates fatty acid oxidation, resulting in steatosis.

Comments are closed.